Your session is about to expire
Maxalt vs Zomig
Introduction
For patients suffering from migraine attacks, certain drugs that alter the activity of serotonin—a neurotransmitter in the brain—can help in managing and relieving symptoms. Maxalt (rizatriptan) and Zomig (zolmitriptan) are two such medications commonly prescribed for treating acute migraines. They each impact serotonin activity differently, but both have been shown to be effective in alleviating migraine symptoms including headache pain, nausea, and sensitivity to light or sound.
Maxalt is a selective serotonin receptor agonist specifically designed to target the 5-HT1B/1D receptors located on blood vessels within your brain which helps narrow these vessels thus reducing headache pain. Similarly, Zomig also targets these specific receptors; however, it further aids by blocking other pathways in the brain that can lead to nausea and other common migraine symptoms.
Maxalt vs Zomig Side By Side
| Attribute | Maxalt | Zomig |
|---|---|---|
| Brand Name | Maxalt | Zomig |
| Contraindications | Should not be taken if you have recently used monoamine oxidase inhibitors (MAOIs). | Should not be taken if there is a clear diagnosis of migraine and not for routine headaches or migraines that are different from your usual ones. |
| Cost | For brand name: around $215 for 9 tablets of 10 mg. For generic: prices start at around $11 and can go as high as about $150 depending on quantity. | For brand name: around $250 for 6 nasal sprays of 5 mg. For generic: costs can range between roughly $.50 to near-$15 per day depending on form and quantity. |
| Generic Name | Rizatriptan | Zolmitriptan |
| Most Serious Side Effect | Heart attack symptoms, serotonin syndrome symptoms, stroke symptoms, high levels of serotonin in the body leading to changes in mental status. | Signs of an allergic response, heart attack symptoms, high levels of serotonin in the body--agitation, hallucinations, fever, fast heart rate, overactive reflexes. |
| Severe Drug Interactions | Monoamine oxidase inhibitors (MAOIs). | Monoamine oxidase inhibitors (MAOIs). |
| Typical Dose | Oral dosages typically range from 5-10 mg/dose. | Typically initiated at a dosage of 2.5 mg per dose. |
What is Maxalt?
Rizatriptan (the generic name for Maxalt) and Zolmitriptan (Zomig) are both part of the triptan class of medications, a significant advancement from older forms of migraine treatment drugs. These medications were specifically designed to treat migraines and have been available since the 1990s. Both Rizatriptan and Zolmitriptan function by binding to serotonin receptors in the brain, thus reducing inflammation and constricting blood vessels, which effectively alleviates migraine symptoms. They are prescribed for acute migraine attacks with or without aura in adults. While each has a selective influence on serotonin receptors with minimal impact on other neurotransmitters, this targeted approach results in fewer side effects compared to other treatments that may affect a wider range of neurotransmitters.
What conditions is Maxalt approved to treat?
Maxalt is approved for the treatment of acute migraine attacks with or without aura in adults:
- Acute, severe migraine attacks
- Migraine associated with sensitivity to light and sound
- Migraines accompanied by nausea
Zomig on the other hand, is also approved for management of acute migraines in both adults and pediatric patients aged 12 years and older:
- Acute, severe migraine attacks
- Treatment of migraines with or without aura
How does Maxalt help with these illnesses?
Maxalt helps to manage migraines by stimulating serotonin (5-HT1) receptors in the brain. It does this by mimicking the action of serotonin, a neurotransmitter that acts as a messenger in the brain and throughout the body. Serotonin plays an important role in pain regulation, sleep patterns, mood amongst other things. Maxalt's specific target is a subset of these receptors involved primarily in constricting blood vessels within the head, thereby alleviating migraine symptoms.
On the other hand, Zomig also works on similar principles but differs slightly in its chemical composition which may make it more suitable for some individuals over others due to possible differences in side effects or effectiveness. Both drugs aim at providing relief from debilitating migraine headaches and helping patients better manage their condition.
What is Zomig?
Zomig is a brand name for zolmitriptan, which is a serotonin (5-HT) 1B/1D receptor agonist, or triptan. This means it stimulates the action of serotonin in the brain, constricting blood vessels and reducing inflammation to alleviate migraine symptoms. Zolmitriptan was first approved by the FDA in 1997. As it is not an NSAID or opioid analgesic, it does not have their common side effects such as gastrointestinal issues or risk of dependence. Instead, its side-effect profile includes sensations of tingling or warmth (paresthesia), dry mouth, dizziness and throat discomfort - different from medications like Maxalt (rizatriptan). Importantly for patients with migraines unresponsive to "typical" over-the-counter painkillers like ibuprofen or paracetamol/acetaminophen, Zomig can provide targeted relief without causing excessive sedation.
What conditions is Zomig approved to treat?
Zomig is a well-established medication in the treatment of:
- Acute migraines, with or without aura
- Cluster headaches
This drug has proven efficacy and has been widely prescribed for years because it provides rapid relief from headache pain and associated migraine symptoms.
How does Zomig help with these illnesses?
Zomig is a type of triptan medication, designed to treat migraines. It functions by constricting blood vessels around the brain and reducing substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, as well as other migraine symptoms. Zomig accomplishes this by stimulating serotonin receptors in the brain which causes the muscles surrounding the blood vessels in the brain to contract and narrow. This helps alleviate a patient's migraine symptoms by relieving swelling and other inflammatory responses that may contribute to headaches.
Like Maxalt, another triptan drug used for similar purposes, Zomig does not prevent future migraines or lessen how often you get migraine attacks but it can help manage your acute episodes effectively when they occur. However, Zomig has an additional advantage over some other medications in its class because it is available not only as a standard tablet form but also as an orally disintegrating tablet and nasal spray for those who struggle with swallowing pills during a migraine attack.
How effective are both Maxalt and Zomig?
Both rizatriptan (Maxalt) and zolmitriptan (Zomig) are effective medications used in treating acute migraines. They both belong to the class of drugs known as triptans, which target a specific serotonin receptor subtype (5HT1B/1D), resulting in constriction of the dilated blood vessels that contribute to migraine headaches. Maxalt was approved by the FDA in 1998, while Zomig followed a year later.
Direct comparisons between Maxalt and Zomig show similar efficacy rates for both medicines, with most patients experiencing significant relief within two hours after administration. In fact, one clinical trial reported no major difference between rizatriptan and zolmitriptan concerning pain-free rates at two hours post-dose.
A review study published in 2002 revealed that Maxalt begins alleviating symptoms within thirty minutes of consumption and reaches peak effectiveness around two hours post-drug intake. The same study showed an excellent safety profile for this drug across different age groups and populations including elderly patients. It also noted that rizatriptan is one of the most commonly prescribed medicines from its class due to its consistent effectiveness.
In contrast, a meta-analysis conducted in 2015 suggested that while Zomig has beneficial effects against migraines compared to placebo treatment, it may be less preferred than other triptans like sumatriptan or eletriptan due to slightly lower response rate at two-hour mark post-administration. However, it's important to remember that individual responses can vary greatly; some patients find more relief with zolmitriptan than other treatments.
Despite these minor differences in pharmacokinetics or comparative studies' results, choosing between rizatriptan or zolmitripan often comes down to patient preference based on their own experiences with side effects or drug efficiency.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Maxalt typically prescribed?
Oral dosages of Maxalt typically range from 5-10 mg/dose, but research has shown that a 5 mg dose is usually effective for relieving migraine symptoms in most people. Adolescents may be started on a lower dose of 5 mg. For both groups, if the migraine does not improve after the initial dose, another dose may be taken after two hours. However, no more than three doses should be taken in any 24-hour period. Similarly with Zomig, oral dosages normally range between 2.5–5mg per day and these are found to effectively reduce acute migraine attacks in many individuals. Dosage can be increased up to maximum of 10mg per day only if there is no response within two hours of taking initial dosage.
At what dose is Zomig typically prescribed?
Zomig, also known as Zolmitriptan, is typically initiated at a dosage of 2.5 mg per dose. If the migraine has not resolved by two hours after taking Zomig, or returns after a transient improvement, a second dose may be administered at least 2 hours after the first dose. The maximum daily intake should not exceed 10 mg in any 24 hour period. It's important to note that treatment with Zomig should be used only where there is a clear diagnosis of migraine and not for routine headaches or migraines that are different from your usual ones.
What are the most common side effects for Maxalt?
Common side effects of Maxalt (Rizatriptan) can include:
- Dizziness
- Fatigue or weakness
- Dry mouth
- Sleepiness/drowsiness (Somnolence)
- Nausea or vomiting
- Paresthesia (pins and needles feeling)
- Chest, throat, neck, or jaw pain/tightness/pressure
On the other hand, Zomig (Zolmitriptan) has similar but also some different side effects such as:
- Sensations of tingling, heat, heaviness or pressure
- Unusual taste in your mouth after using nasal spray version
-Dry mouth
-Nausea
-Drowsiness/sleepiness
-Sensitivity to light and sound.
Both these medications are used for treating acute migraines; however their side-effects may vary based on individuals' health condition. Always consult with a healthcare provider before changing medications.
Are there any potential serious side effects for Maxalt?
Maxalt and Zomig are both used to treat migraines, but they can cause different side effects. While rare, serious side effects from Maxalt might include:
- Heart attack symptoms: chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating
- Serotonin syndrome symptoms: agitation, hallucinations (seeing things that aren't there), fever, overactive reflexes/fast heartbeat, loss of coordination/feeling faint
- Stroke symptoms: sudden numbness/weakness on one side of the body, slurred speech
- High levels of serotonin in the body leading to changes in mental status
Zomig's potential serious side effects also include:
- Signs of an allergic reaction such as difficulty breathing; swelling of face/lips/tongue/throat; severe dizziness or rash
- Chest/jaw/left arm pain -Fainting with a slow/fast heartbeat and severe stomach/abdominal pain
If you experience any adverse reactions while taking either drug seek immediate medical attention.
What are the most common side effects for Zomig?
Zomig, like Maxalt, is a medication used to treat migraines. However, it has its own set of potential side effects:
- Dry mouth or unusual taste
- Sensitivity to heat or cold
- Nausea or vomiting
- Dizziness or feeling unsteady
- Muscle weakness or lack of coordination
- Increased sweating
- Rapid heartbeat
- Feeling agitated or restless
- Skin rash
-Decreased sensation in certain parts of the body
-Increased urination frequency
-Potential for weight loss due to decreased appetite
-Mild headache (apart from migraine) -Joint pain.
Always remember that each individual may respond differently to medications and not everyone will experience all listed side effects. Always consult with your healthcare provider when choosing between different medications.
Are there any potential serious side effects for Zomig?
While Zomig is generally well-tolerated, it does have the potential to cause serious side effects in rare cases. These may include:
- Signs of an allergic response: hives; difficulty breathing; swelling of your face, lips, tongue, or throat
- Heart attack symptoms: chest pain or pressure, pain spreading to your jaw or shoulder accompanied by nausea and sweating
- High levels of serotonin in the body--agitation, hallucinations, fever, fast heart rate, overactive reflexes
- Unusual changes in mood or behavior such as confusion
- Blurred vision and/or tunnel vision
- Severe headache with neck stiffness along with increased sensitivity to light and purple spots on the skin (indicative of a condition called 'serotonin syndrome')
If you experience any such side effects after taking Zomig for migraines stop using this medication immediately and seek medical attention right away.
Contraindications for Maxalt and Zomig?
Maxalt and Zomig are medications commonly used to treat severe migraine attacks. However, if you notice your symptoms worsening or experiencing unusual side effects such as palpitations, shortness of breath, or chest pain after taking these drugs, please seek immediate medical attention.
Neither Maxalt nor Zomig should be taken if you have recently used monoamine oxidase inhibitors (MAOIs), a type of antidepressant. It's essential to always inform your healthcare provider about all the medications you're currently using; MAOIs will require a period of about two weeks to clear from the system before starting treatment with either Maxalt or Zomig to prevent potentially harmful interactions.
How much do Maxalt and Zomig cost?
For the brand name versions of these drugs:
- The price for 9 tablets of Maxalt (10 mg) averages around $215, which works out to about $24/day, depending on your dose.
- The price for 6 nasal sprays of Zomig (5 mg) is roughly $250, working out to approximately $42/day.
Thus, if you are in the higher dosage range for Maxalt (i.e., 20 mg/day), then brand-name Zomig is less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these migraine medications is right for you.
For the generic versions of Maxalt (rizatriptan) and Zomig (zolmitriptan), costs are significantly lower:
- Rizatriptan (10mg tablets) comes in packs starting from just 3 tablets up to larger quantities like 18 or more. Prices start at around $11 but can go as high as about $150 depending on quantity purchased. This equates to an approximate daily cost ranging from about $.60 up to potentially over $16 / day when taking doses as recommended by your clinician.
- Generic Zolmitriptan also varies greatly in pricing based off quantity purchased and form factor - nasal spray versus oral tablet - with potential costs spanning anywhere between roughly $.50 all the way up towards near-$15 per day.
Popularity of Maxalt and Zomig
Rizatriptan, both in its generic form and under brand names such as Maxalt, was estimated to have been prescribed to about 2 million people in the US in 2020. Rizatriptan accounted for roughly 20% of triptan prescriptions (a class of medication used specifically for severe headaches like migraines) in the US. Its use has seen a steady increase since its introduction due to its efficiency at relieving migraine symptoms.
Zolmitriptan, including brand versions such as Zomig, was prescribed to around 1.3 million people in the USA in 2020. In terms of triptan prescriptions within the US, zolmitriptan accounts for approximately a steady figure of around 10% over recent years. Both rizatriptan and zolmitriptan are considered effective options for migraine sufferers but individual response can vary significantly between patients which is why having multiple options available is beneficial.
Conclusion
Both Maxalt (rizatriptan) and Zomig (zolmitriptan) are used to treat migraines, with a long-standing record of effectiveness backed by substantial clinical research. In some cases, the medications may be combined for more effective relief, but this requires careful consideration from a physician due to potential drug interactions. Both drugs work by constricting blood vessels in the brain that swell during migraines; however, they have different pharmacokinetic profiles which influence their onset and duration of action.
Maxalt is often favored as it typically works faster than Zomig - usually within 2 hours compared to Zomig's average 4-hour response time. However, both medicines are generally considered first-line acute treatments for moderate-to-severe migraine attacks.
Both Maxalt and Zomig are available in generic forms providing cost savings especially when paying out-of-pocket. Just like Prozac and Wellbutrin mentioned above, these migraine medications might require an adjustment period as well since not all patients respond immediately or equally.
Side effects between two drugs are similar being generally well-tolerated but patients must closely monitor any changes after taking either medication. The most common side effects include dizziness, weakness or fatigue – if these worsen over time or become severe medical attention should be sought immediately.
Other Trials to Consider
Popular Categories
Refrences
- Solomon, G. D., Cady, R. K., Klapper, J. A., Earl, N. L., Saper, J. R., Ramadan, N. M., & The 042 Clinical Trial Study Group. (1997, November). Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1212/wnl.49.5.1219
- Dahlof, C., & Lines, C. (1999, May). Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine. Expert Opinion on Investigational Drugs. Informa Healthcare.http://doi.org/10.1517/13543784.8.5.671
- Lipton, R., & Stewart, W. (1997, October). Clinical applications of zolmitriptan (Zomig™, 311C90). Cephalalgia. SAGE Publications.http://doi.org/10.1177/0333102497017s1807
- Rapoport, A. M., Bigal, M. E., Tepper, S. J., & Sheftell, F. D. (2004, January). Zolmitriptan (Zomig®). Expert Review of Neurotherapeutics. Informa UK Limited.http://doi.org/10.1586/14737175.4.1.33
- Rapoport, A. M., Ramadan, N. M., Adelman, J. U., Mathew, N. T., Elkind, A. H., Kudrow, D. B., … The 017 Clinical Trial Study Group†. (1997, November). Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine. Neurology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1212/wnl.49.5.1210
- Wellington, K., & Plosker, G. L. (2002). Rizatriptan. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200262100-00007